Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

TRACON Pharmaceuticals Inc (TCON)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow TRACON Pharma's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.870 -0.020    -1.06%
13:00:01 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 70,116
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.850 - 1.969
TRACON Pharma 1.870 -0.020 -1.06%

TRACON Pharmaceuticals Inc Company Profile

 
Get an in-depth profile of TRACON Pharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

17

Equity Type

ORD

TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel targeted therapeutics for cancer in the United States. Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the treatment of refractory soft tissue sarcoma; and YH001, an investigational humanized cytotoxic T-lymphocyte-associated protein 4 IgG1 monoclonal antibody that is in Phase I clinical trial for the treatment of various cancer indications. The company’s clinical stage products also include TRC102, a small molecule that is in Phase II clinical trial for the treatment of mesothelioma, and in Phase I clinical trial to treat solid tumors, lung cancer, and glioblastoma; and TJ004309, a CD73 antibody that is in Phase I clinical development for the treatment of solid tumors. In addition, it is developing bispecific antibodies, which are in preclinical stage. It has collaboration and license agreements with 3D Medicines Co., Ltd. and Jiangsu Alphamab Biopharmaceuticals Co., Ltd. for the development of envafolimab; I-Mab Biopharma for the development of CD73 antibody TJ004309 and bispecific antibodies; and cooperative research and development agreement with National Cancer Institute. The company was formerly known as Lexington Pharmaceuticals, Inc. and changed its name to TRACON Pharmaceuticals, Inc. in March 2005. TRACON Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in San Diego, California.

Contact Information

Address 4350 La Jolla Village Drive Suite 800
San Diego, 92122
United States
Phone 858 550 0780
Fax 858 550 0786

Top Executives

Name Age Since Title
Stanton Gerson - - Member of the Scientific Advisory Board
William R. LaRue 70 2014 Independent Director
Martin A. Mattingly 64 2014 Independent Director
Stephen T. Worland 63 2015 Independent Director
James Rainer Twiford 68 2008 Independent Director
Saundra Pelletier 51 2020 Independent Director
Lisa Johnson-Pratt 59 2021 Independent Director
Carol C. Lam 63 2021 Independent Director
Charles P. Theuer 60 2006 Chairman, CEO & President
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TCON Comments

Write your thoughts about TRACON Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
종수 한
종수 한 Apr 15, 2024 10:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what a fork stock
Aabbu Gautam
Aabbu Gautam Nov 10, 2023 11:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hello
Zack Fick
Zack Fick Jun 29, 2023 12:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Boom! Love it. Go to zero now!
Zack Fick
Zack Fick Jun 27, 2023 12:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Back in short. 30k shares. Should not have covered at .39c PT now .32c
Zack Fick
Zack Fick Jun 23, 2023 3:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Covered. Thx for the $4k
Zack Fick
Zack Fick Jun 22, 2023 7:33PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Already up 18% in two days. Easy money shorting scammy biotechs.
Zack Fick
Zack Fick Jun 21, 2023 9:03PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Short to .25c
MIKHAIL KUZNETSOV
MIKHAIL KUZNETSOV Feb 02, 2022 8:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Again , we enter this game with friends for $ 2.75 . There is a catalyst this time I hope for more .Lets go to the moon !!!!!!!!!!!!!!
Khalid Zms
Khalid Zms Sep 24, 2020 9:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any news
Carlos Andres
Carlos Andres Sep 03, 2020 11:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
strong?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email